We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
Cap. Flow
+$113M
Cap. Flow %
9.6%
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$12.6M
2
MFC icon
Manulife Financial
MFC
+$7.56M
3
GKOS icon
Glaukos
GKOS
+$7.01M
4
AMZN icon
Amazon
AMZN
+$6.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.26M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$11.7M
2
UNH icon
UnitedHealth
UNH
+$11.3M
3
IRTC icon
iRhythm Holdings
IRTC
+$9.63M
4
HALO icon
Halozyme
HALO
+$8.33M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 46.65%
2 Financials 13.97%
3 Consumer Discretionary 13.94%
4 Technology 8.36%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANSS
76
DELISTED
Ansys
ANSS
$3.77M 0.32%
+15,752
New +$4.17M
KO icon
77
Coca-Cola
KO
$373B
$3.68M 0.31%
58,446
+5,383
+10% +$341K
ITUB icon
78
Itaú Unibanco
ITUB
$81.6B
$3.64M 0.31%
963,050
-456,146
-32% -$2.03M
PG icon
79
Procter & Gamble
PG
$335B
$3.59M 0.3%
24,996
+1,517
+6% +$228K
ALLO icon
80
Allogene Therapeutics
ALLO
$714M
$3.48M 0.29%
305,253
-195,966
-39% -$1.74M
PEP icon
81
PepsiCo
PEP
$189B
$3.47M 0.29%
20,832
-1,741
-8% -$293K
ARE icon
82
Alexandria Real Estate Equities
ARE
$8.27B
$3.46M 0.29%
+23,874
New +$4.05M
TXG icon
83
10x Genomics
TXG
$7.52B
$3.42M 0.29%
75,594
-4,682
-6% -$243K
NTLA icon
84
Intellia Therapeutics
NTLA
$1.69B
$3.38M 0.29%
65,316
-13,773
-17% -$699K
SIVB
85
DELISTED
SVB Financial Group
SIVB
$3.35M 0.28%
+8,474
New +$3.99M
NEE icon
86
NextEra Energy
NEE
$179B
$3.29M 0.28%
42,518
+7,555
+22% +$575K
DHR icon
87
Danaher
DHR
$145B
$3.28M 0.28%
14,579
+687
+5% +$158K
CPAY icon
88
Corpay
CPAY
$26.9B
$3.27M 0.28%
+15,557
New +$3.71M
NTRA icon
89
Natera
NTRA
$45.5B
$3.26M 0.28%
91,949
-106,875
-54% -$3.96M
SGMO
90
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.22M 0.27%
778,769
-81,933
-10% -$354K
FATE icon
91
Fate Therapeutics
FATE
$317M
$3.2M 0.27%
129,213
-42,112
-25% -$1.16M
AMAT icon
92
Applied Materials
AMAT
$435B
$3.14M 0.27%
34,513
+22,460
+186% +$2.46M
EDIT icon
93
Editas Medicine
EDIT
$436M
$3.07M 0.26%
259,832
-121,131
-32% -$1.62M
ELAN icon
94
Elanco Animal Health
ELAN
$11.1B
$2.95M 0.25%
+150,448
New +$3.56M
NKE icon
95
Nike
NKE
$60.1B
$2.9M 0.25%
28,411
+198
+0.7% +$23.4K
YETI icon
96
Yeti Holdings
YETI
$3.85B
$2.84M 0.24%
+65,729
New +$3.19M
YMAB
97
DELISTED
Y-mAbs Therapeutics
YMAB
$2.74M 0.23%
180,933
-40,841
-18% -$476K
AZPN
98
DELISTED
Aspen Technology Inc
AZPN
$2.67M 0.23%
+14,512
New +$2.58M
EL icon
99
Estee Lauder
EL
$31.7B
$2.62M 0.22%
+10,292
New +$2.61M
CDNA icon
100
CareDx
CDNA
$2.45B
$2.62M 0.22%
121,879
+63,327
+108% +$1.76M
2 3
4
5 6

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review

As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
  • Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
  • Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
  • Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.